Lee Ann Lynn Girotti

This inventor holds 14 USPTO granted patents and 9 published patent applications and 3 EPO patents. Top assignee: Heron Therapeutics, Inc.. Active years: 2017-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Lee Ann Lynn Girotti. Retrieved from https://idiyas.com/inventor/lee-ann-lynn-girotti

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 14 (Patent Applications = 9)

% Patents Active = 100.0

EPO Patents = 3 (Patent Applications = 5)

Average Co-Inventor Count = 2.0

ph-index = 3

Forward Citations = 51(Granted Patents)

Company Filing History:

14 out of 35

Heron Therapeutics, Inc.

patents

Years Active: 2017-2025

Loading Chart...

14 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12318376 - Compositions of a polyorthoester and an aprotic solvent (2025-06-03),

2. 11844837 - Compositions of a polyorthoester and an organic acid excipient (2023-12-19),

3. 11413350 - Long-acting polymeric delivery systems (2022-08-16),

4. 11253504 - Compositions of a polyorthoester and an aprotic solvent (2022-02-22),

5. 11083797 - Long-acting polymeric delivery systems (2021-08-10),

6. 11083730 - Long-acting polymeric delivery systems (2021-08-10),

7. 10980886 - Compositions of a polyorthoester and an organic acid excipient (2021-04-20),

8. 10898575 - Long-acting polymeric delivery systems (2021-01-26),

9. 10632199 - Long-acting polymeric delivery systems (2020-04-28),

10. 10398686 - Compositions of a polyorthoester and an aprotic solvent (2019-09-03),

11. 10213510 - Long-acting polymeric delivery systems (2019-02-26),

12. 10098957 - Long-acting polymeric delivery systems (2018-10-16),

13. 9801945 - Long-acting polymeric delivery systems (2017-10-31),

14. 9694079 - Long-acting polymeric delivery systems (2017-07-04),

Title: Innovations by Lee Ann Lynn Girotti: Pioneering Biodegradable Delivery Systems

Introduction

Lee Ann Lynn Girotti, a prominent inventor based in San Bruno, California, has made significant strides in the field of biodegradable materials and drug delivery systems. With a remarkable portfolio of 14 patents, her innovations are paving the way for novel approaches in the pharmaceutical industry, focusing on enhancing the efficacy and safety of drug administration.

Latest Patents

Among her latest inventions are notable patents related to compositions of polyorthoesters and various solvents. One such patent describes delivery systems and compositions that comprise a biodegradable polyorthoester polymer combined with an aprotic solvent. This innovative approach modulates the release rate of drugs from the composition, allowing for tailored therapeutic effects. Depending on the desired outcome, the solvent may be rapidly or slowly released upon administration, thereby providing flexibility in drug delivery.

Another important patent focuses on delivery systems featuring a biodegradable polyorthoester polymer along with an organic acid excipient and a basic drug. This composition not only enhances drug stability but also improves patient outcomes through controlled release mechanisms.

Career Highlights

Lee Ann Lynn Girotti is currently associated with Heron Therapeutics, Inc., where her expertise continues to drive advancements in drug delivery technology. Throughout her career, she has been committed to transformative research, contributing to the development of innovative solutions in the biomedical arena.

Collaborations

In her professional journey, she collaborates with notable figures in her field, including her coworker Thomas B. Ottoboni. Together, they work towards pioneering applications that utilize biodegradable materials for improved therapeutic outcomes, showcasing the importance of collaboration in scientific research and innovation.

Conclusion

Lee Ann Lynn Girotti's work exemplifies the frontier of innovation in drug delivery systems, combining biotechnology and material science to create impactful solutions. Her contributions significantly enhance the landscape of pharmaceutical therapies, demonstrating the potential of biodegradable polymers in improving patient care and treatment efficiency. As she continues her work at Heron Therapeutics, her patents will undoubtedly inspire further advancements in the industry.

Profile summary based on public USPTO records.